Peptomer Therapeutics has marked a significant achievement by securing a prestigious grant from the Biotechnology Industry Research Assistance Council (BIRAC). This accomplishment highlights the company’s unwavering commitment to advancing innovative solutions in the battle against Antimicrobial Resistance (AMR). With this substantial funding, Peptomer Therapeutics is primed to expedite its research and development initiatives in the realm of antimicrobial resistance, furthering its impact in the field.